| 中国骨肉瘤综合治疗现状与展望 |
| |
| 引用本文： | 牛晓辉. 中国骨肉瘤综合治疗现状与展望[J]. 中华解剖与临床杂志, 2019, 24(1): 1-5. DOI: 10.3760/cma.j.issn.2095-7041.2019.01.001 |
| |
| 作者姓名： | 牛晓辉 |
| |
| 作者单位： | 北京积水潭医院骨肿瘤科 100035 |
| |
| 摘 要： | 骨肉瘤尽管是最常见的骨原发恶性肿瘤,但其年发病率仅有百万分之三。在20世纪70年代之前,其预后很差,随着化疗等综合治疗的进步,骨肉瘤的预后有了显著的改善。本文对国际骨肉瘤认识的发展、我国骨肉瘤综合治疗的发展情况、规范化进程以及治疗展望进行述评,期望藉此使读者了解我国骨肉瘤治疗的历史和现状。
|
| 关 键 词： | 骨肉瘤 肿瘤辅助疗法 化学疗法 辅助 外科手术 |
| 收稿时间： | 2018-11-12 |
Status and prospect of the combined therapy for osteosarcoma in China |
| |
| Niu Xiaohui. Status and prospect of the combined therapy for osteosarcoma in China[J]. Chinese Journal of Anatomy and Clinics, 2019, 24(1): 1-5. DOI: 10.3760/cma.j.issn.2095-7041.2019.01.001 |
| |
| Authors: | Niu Xiaohui |
| |
| Affiliation: | Department of Orthopaedic Oncology Surgery, Beijing Jishuitan Hospital, Beijing 100035, China |
| |
| Abstract: | Although osteosarcoma is the most common malignant bone tumor, its annual incidence is only three per million. Before the 1970s, the prognosis of osteosarcoma was very poor. With the advancement of comprehensive treatments such as chemotherapy, the prognosis of osteosarcoma has been significantly improved. This article attempts to review the development of osteosarcoma treatment in the world, the development of comprehensive treatment in China, the standardization process and the treatment prospects, and hope to present the readers the history and current status of osteosarcoma in China, and the future development as well. |
| |
| Keywords: | Osteosarcoma Neoadjuvant therapy Chemotherapy, adjuvant Surgical procedures, operative |
| 本文献已被 维普 万方数据 等数据库收录！ |
| 点击此处可从《中华解剖与临床杂志》浏览原始摘要信息 |
|
点击此处可从《中华解剖与临床杂志》下载全文 |
|
